Expression and lytic efficacy assessment of the Staphylococcus aureus phage SA4 lysin gene

Journal of Veterinary Science

Volumn 14, Issue 1, 2013, Pages 37-43

  Mishra, Anil Kumar ^a   Rawat, Mayank ^b   Viswas, Konasagara Nagaleekar ^b   Abhishek, ^b   Kumar, Sujeet ^c   Reddy, Manjunatha ^a  

^a Central Institute for Research on Goat   (India)

^b INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^c ICAR CENTRAL INSTITUTE OF BRACKISHWATER AQUACULTURE   (India)

Author keywords

Lysin; Mastitis; Phage; Staphylococcus aureus

Indexed keywords

LYSIN; MUCOPROTEIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BACTERIOPHAGE; GENE EXPRESSION REGULATION; GENETICS; MASTITIS; METABOLISM; METHODOLOGY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHYLOGENY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGE; VIROLOGY;

LYSIN; MASTITIS; PHAGE; STAPHYLOCOCCUS AUREUS;

ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, VIRAL; MUCOPROTEINS; PHYLOGENY; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGES;

BOVINAE; ESCHERICHIA COLI; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 84877005531     PISSN: 1229845X     EISSN: 1976555X     Source Type: Journal    
DOI: 10.4142/jvs.2013.14.1.37     Document Type: Article

References (34)

1. Andersson I, van Scheltinga ACT, Valegård K. Towards new ß-lactam antibiotics. Cell Mol Life Sci 2001, 58, 1897-1906.
2. Bishop EJ, Howden BP. Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions. Expert Opin Emerg Drugs 2007, 12, 1-22.
3. Bon J, Mani N, Jayaswal RK. Molecular analysis of lytic genes of bacteriophage 80a of Staphylococcus aureus. Can J Microbiol 1997, 43, 612-616.
4. Borysowski J, Weber-Dabrowska B, Górski A. Bacteriophage endolysins as a novel class of antibacterial agents. Exp Biol Med (Maywood) 2006, 231, 366-377.
5. DeGraves FJ, Fetrow J. Economics of mastitis and mastitis control. Vet Clin North Am Food Anim Pract 1993, 9, 421-434.
6. Deluyker HA, Chester ST, Van Oye SN. A multilocation clinical trial in lactating dairy cows affected with clinical mastitis to compare the efficacy of treatment with intramammary infusions of a lincomycin/neomycin combination with an ampicillin/cloxacillin combination. J Vet Pharmacol Ther 1999, 22, 274-282.
7. Donovan DM. Bacteriophage and peptidoglycan degrading enzymes with antimicrobial applications. Recent Pat Biotechnol 2007, 1, 113-122.
8. Doughty CC, Mann JA. Purification and properties of a bacteriophage-induced cell wall peptidase from Staphylococcus aureus. J Bacteriol 1967, 93, 1089-1095.
9. Etlinger HM, Caspers P, Matile H, Schoenfeld HJ, Stueber D, Takacs B. Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. Infect Immun 1991, 59, 3498-3503.
10. Gill JJ, Pacan JC, Carson ME, Leslie KE, Griffiths MW, Sabour PM. Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle. Antimicrob Agents Chemother 2006, 50, 2912-2918.
11. Heath ACG, Broadwell AH, Chilcott CN, Wigley PJ, Shoemaker CB. Efficacy of native and recombinant Cry1B protein against experimentally induced and naturally acquired ovine myiasis (fly strike) in sheep. J Econ Entomol 2004, 97, 1797-1804.
12. Loeffler JM, Fischetti VA. Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains. Antimicrob Agents Chemother 2003, 47, 375-377.
13. Loessner MJ, Gaeng S, Scherer S. Evidence for a holin-like protein gene fully embedded out of frame in the endolysin gene of Staphylococcus aureus bacteriophage 187. J Bacteriol 1999, 181, 4452-4460.
14. Loessner MJ, Gaeng S, Wendlinger G, Maier SK, Scherer S. The two-component lysis system of Staphylococcus aureus bacteriophage Twort: a large TTG-start holin and an associated amidase endolysin. FEMS Microbiol Lett 1998, 162, 265-274.
15. Loessner MJ, Maier SK, Daubek-Puza H, Wendlinger G, Scherer S. Three Bacillus cereus bacteriophage endolysins are unrelated but reveal high homology to cell wall hydrolases from different bacilli. J Bacteriol 1997, 179, 2845-2851.
16. Loessner MJ, Wendlinger G, Scherer S. Heterogeneous endolysins in Listeria monocytogenes bacteriophages: a new class of enzymes and evidence for conserved holin genes within the siphoviral lysis cassettes. Mol Microbiol 1995, 16, 1231-1241.
17. Lorch A. Bacteriophages: An alternative to antibiotics? Biotechnol Dev Monit 1999, 39, 14-17.
18. Mann NH. The potential of phages to prevent MRSA infections. Res Microbiol 2008, 159, 400-405.
19. Markel DE, Eklund C. Isolation, characterization, and classification of three bacteriophage isolates for the genus Levinea. Int J Syst Bacteriol 1974, 24, 230-234.
20. Mishra AK, Rawat M, Abhishek, Sureshkannan. Characterization and lytic activity of endolysin induced by bacteriophage SA4 against mastitogenic isolates of Staphylococcus of bovine origin. Indian Vet J 2012, 89, 24-26.
21. Morita M, Tanji Y, Orito Y, Mizoguchi K, Soejima A, Unno H. Functional analysis of antibacterial activity of Bacillus amyloliquefaciens phage endolysin against Gram-negative bacteria. FEBS Lett 2001, 500, 56-59.
22. Navarre WW, Ton-That H, Faull KF, Schneewind O. Multiple enzymatic activities of the murein hydrolase from staphylococcal phage ?11. Identification of a D-alanylglycine endopeptidase activity. J Biol Chem 1999, 274, 15847-15856.
23. Nelson D, Loomis L, Fischetti VA. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci USA 2001, 98, 4107-4112.
24. O'Flaherty S, Coffey A, Meaney W, Fitzgerald GF, Ross RP. The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol 2005, 187, 7161-7164.
25. Park SC, Shimamura I, Fukunaga M, Mori KI, Nakai T. Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control. Appl Environ Microbiol 2000, 66, 1416-1422.
26. Paul VD, Rajagopalan SS, Sundarrajan S, George SE, Asrani JY, Pillai R, Chikkamadaiah R, Durgaiah M, Sriram B, Padmanabhan S. A novel bacteriophage tailassociated muralytic enzyme (TAME) from phage K and its development into a potent a antistaphylococcal protein. BMC Microbiol 2011, 11, 226.
27. Ralston DJ, Baer BS, Lieberman M, Krueger AP. Virolysin: a virus-induced lysine from staphylococcal phage lysates. Proc Soc Exp Biol Med 1955, 89, 502-507.
28. Rodríguez L, Martínez B, Zhou Y, Rodríguez A, Donovan DM, García P. Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88. BMC Microbiol 2011, 11, 138.
29. Rodríguez-Rubio L, Gutiérrez D, Martínez B, Rodríguez A, García P. Lytic activity of LysH5 endolysin secreted by Lactococcus lactis using the secretion signal sequence of bacteriocin Lcn972. Appl Environ Microbiol 2012, 78, 3469-3472.
30. Sambrook J, Russell DW. Molecular Cloning: a Laboratory Manual. 3rd ed. Vol. 3. pp.15.14-15.18, Cold Spring Harbor Laboratory Press, New York, 2001.
31. Sass P, Bierbaum G. Lytic activity of recombinant bacteriophage ?11 and ?12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl Environ Microbiol 2007, 73, 347-352.
32. Shearman C, Underwood H, Jury K, Gasson M. Cloning and DNA sequence analysis of a Lactococcus bacteriophage lysin gene. Mol Gen Genet 1989, 218, 214-221.
33. Sonstein SA, Hammel JM, Bondi A. Staphylococcal bacteriophage-associated lysin: a lytic agent active against Staphylococcus aureus. J Bacteriol 1971, 107, 499-504.
34. Yoong P, Schuch R, Nelson D, Fischetti VA. Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium. J Bacteriol 2004, 186, 4808-4812.